1 Cardiovascular Medicine, Department of Internal Medicine, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA.
2 Division of Cardiovascular Medicine, Department of Internal Medicine, Frankel Cardiovascular Center, University of Michigan, Ann Arbor, MI, USA.
Vasc Med. 2019 Apr;24(2):122-131. doi: 10.1177/1358863X18821159.
Venous thromboembolism (VTE) is a common vascular condition. New medications are available to prevent hospital-associated VTE. Strategies are being studied to increase appropriate diagnostic testing utilization. Management of deep vein thrombosis (DVT) and pulmonary embolism (PE) has evolved with the advent of new anticoagulant options and catheter-directed intervention. In light of this, providers are commonly challenged with the decision regarding inpatient versus outpatient management. Which patients require long-term (> 3 months) anticoagulation is challenging and multiple clinical prediction models may be used to help determine the risk-benefit ratio in each patient. The management of VTE is an ongoing area of research and is rapidly evolving.
静脉血栓栓塞症(VTE)是一种常见的血管疾病。有新的药物可用于预防医院相关性 VTE。目前正在研究策略以增加适当的诊断检测利用。随着新型抗凝药物和导管介入治疗的出现,深静脉血栓形成(DVT)和肺栓塞(PE)的管理也在不断发展。鉴于此,临床医生通常面临着住院与门诊管理之间的决策。哪些患者需要长期(> 3 个月)抗凝治疗具有挑战性,并且可以使用多种临床预测模型来帮助确定每个患者的风险效益比。VTE 的管理是一个持续的研究领域,并且正在迅速发展。